PMID: 1841609Dec 1, 1991Paper

Is prevention of vascular dementia possible? The Syst-Eur Vascular Dementia Project

Aging : Clinical and Experimental Research
F ForetteP W De Leeuw


Vascular dementia (VD) is the second most common cause of dementia in the elderly after Alzheimer's disease (AD). Prevalence estimates from community surveys indicate that, on average, 5% of persons over 65 and 15 to 20% of people over 80 suffer from "severe dementia". Clinico-pathological studies have shown that AD accounts for 50 to 60% of the cases and VD for about 10 to 20%; 20% of the patients have both disorders. The incidence rate of VD ranges from 7 per 1,000 person-years in normal volunteers to 16 per 1,000 person-years in subjects with risk factors for strokes, particularly high blood pressure. The only effective therapeutic approach to VD is the prevention of strokes, mainly through the treatment of hypertension; however, none of the therapeutic trials has included VD prevention as one of its treatment goals. Syst-Eur Study is a European placebo controlled trial which aims to determine whether morbidity and mortality are changed when elderly patients (60 years and over) with isolated systolic hypertension are treated. In this trial, the incidence of VD will be carefully recorded during the five year follow-up of the expected 3,000 patients. The present side project to the Syst-Eur trial will specifically address the ...Continue Reading


Jan 1, 1976·Archives of Neurology·R D Terry
Apr 1, 1976·Journal of Neurology, Neurosurgery, and Psychiatry·G A BroeW J McLennan
Jul 1, 1976·Stroke; a Journal of Cerebral Circulation·W B KannelP A Wolf
Sep 1, 1975·Archives of Neurology·V C HachinskiL Symon
Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jan 1, 1991·European Archives of Psychiatry and Clinical Neuroscience·M R EastwoodD Roberts
Jan 1, 1991·European Archives of Psychiatry and Clinical Neuroscience·A F Jorm
Jan 1, 1990·Neuroepidemiology·C Loeb, C Gandolfo
Jan 1, 1988·Journal of Cardiovascular Pharmacology·J StaessenA Amery
Jan 1, 1989·International Psychogeriatrics·A Homma, K Hasegawa
Feb 1, 1989·Journal of Neurology·C M Fisher
Jun 1, 1989·Journal of the American Geriatrics Society·J S MeyerJ Lotfi
Apr 1, 1989·Annals of Neurology·R KatzmanW L Ooi
Oct 1, 1988·Stroke; a Journal of Cerebral Circulation·P Scheinberg
Aug 1, 1988·Annals of Neurology·S E NadeauM E Andrew
Nov 1, 1986·British Medical Journal·J Coope, T S Warrender
Nov 1, 1988·Journal of the American Geriatrics Society·B J GurlandS Edlavitch
Aug 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·T ErkinjunttiA Paetau
Dec 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·J S MeyerK F Mortel
Apr 1, 1988·Archives of Internal Medicine·F M GengoP R Kinkel
May 1, 1987·Postgraduate Medical Journal·J M Orgogozo, R Spiegel
Nov 1, 1987·Acta Psychiatrica Scandinavica·A F JormA S Henderson
Jan 1, 1986·Journal of Chronic Diseases·B S Schoenberg
Jan 1, 1987·Stroke; a Journal of Cerebral Circulation·V Babikian, A H Ropper
Jan 1, 1986·European Neurology·A Baethmann, M Jansen
Oct 1, 1986·Archives of Internal Medicine·T ErkinjunttiL Autio
Apr 1, 1985·Journal of the American Geriatrics Society·M FolsteinE M Gruenberg
Jun 1, 1985·Neurology·L L BarclayJ Sansone
Nov 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·P K MölsäE Säkö
Jan 1, 1974·Stroke; a Journal of Cerebral Circulation·R B ShekelleH L Klawans
Sep 1, 1970·Journal of the Neurological Sciences·B E TomlinsonM Roth
Jul 1, 1968·The British Journal of Psychiatry : the Journal of Mental Science·G BlessedM Roth
Nov 1, 1984·Acta Psychiatrica Scandinavica·L V Nilsson

❮ Previous
Next ❯


Jan 29, 1999·Lancet·M PahorW B Applegate
Sep 12, 2000·Current Hypertension Reports·M L Seux, F Forette
Sep 1, 1992·Aging : Clinical and Experimental Research·F ForetteF Boller
Sep 12, 2000·Current Hypertension Reports·J GasowskiJ A Staessen
Jul 27, 2001·Current Hypertension Reports·J G Wang, J A Staessen
Nov 1, 2002·International Clinical Psychopharmacology·G WilcockUNKNOWN MMM 500 group
Oct 27, 2004·Expert Review of Cardiovascular Therapy·Valérie TikhonoffAchille C Pessina
Oct 29, 2008·Current Medical Research and Opinion·Ernest VinyolesDiego Gonzalez-Segura
Jun 13, 1998·Journal of the American Geriatrics Society·J A StaessenF Forette
May 25, 2002·Journal of the American Geriatrics Society·Sidney T BogardusSharon K Inouye
Apr 3, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·A S Rigaud, B Forette
Nov 13, 2001·Current Opinion in Cardiology·H CelisUNKNOWN Systolic Hypertension in Europe Trial Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Annales de cardiologie et d'angéiologie
M L Seux
Archives des maladies du coeur et des vaisseaux
O HanonF Forette
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
J StaessenSystolic Hypertension in Europe Trial Investigators (the Syst-Eur Trial)
The Netherlands Journal of Medicine
F ForetteP Bert
© 2021 Meta ULC. All rights reserved